Novoste 40 mm Seed Train Addresses Clinical Concern Over "Edge" Effect
This article was originally published in The Gray Sheet
Novoste plans to introduce into ongoing European and U.S. clinical trials this quarter a longer seed train for the Beta-Cath radiotherapy catheter system, which is intended to prevent possible restenosis at the edge of the treatment zone of a coronary vessel.
You may also be interested in...
Novoste Corp. is considering further evaluation of its Beta-Cath radiation system using a longer source train and a smaller diameter catheter in conjunction with initial angioplasty treatment.
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.